INTERNATIONAL PATENT: PAM THERAGNOSTICS GMBH FILES APPLICATION FOR "MODIFIED AND UNMODIFIED PEPTIDYL-GLYCINE ALPHA-AMIDATING MONOOXYGENASE (PAM) FOR USE IN THE TREATMENT OR PREVENTION OF CEREBRAL HYPOPERFUSION FOR THE IMPROVEMENT OF CEREBRAL BLOOD FLOW (CBF)"

GENEVA, May 18 -- PAM THERAGNOSTICS GMBH (Neuendorfstr. 15 B16761 Hennigsdorf) filed a patent application (PCT/EP2025/081935) for "MODIFIED AND UNMODIFIED PEPTIDYL-GLYCINE ALPHA-AMIDATING MONOOXYGENASE (PAM) FOR USE IN THE TREATMENT OR PREVENTION OF CEREBRAL HYPOPERFUSION FOR THE IMPROVEMENT OF CEREBRAL BLOOD FLOW (CBF)" on Nov 05, 2025. With publication no. WO/2026/099243, the details related to the patent application was published on May 15, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): BERGMANN, Andreas (c/o PAM Theragnostics GmbHNeuendorfstr. 15 B16761 Hennigsdorf), ILINA, Yulia (c/o P...